tiprankstipranks
Advertisement
Advertisement
Douglas Tsao Maintains Hold on Biohaven, Keeps $10 Price Target Amid Promising but Early Epilepsy Data
PremiumRatingsDouglas Tsao Maintains Hold on Biohaven, Keeps $10 Price Target Amid Promising but Early Epilepsy Data
10d ago
Biohaven reports data from selective Kv7.2/7.3 channel activator program
Premium
The Fly
Biohaven reports data from selective Kv7.2/7.3 channel activator program
10d ago
Biohaven price target lowered to $18 from $21 at Morgan Stanley
Premium
The Fly
Biohaven price target lowered to $18 from $21 at Morgan Stanley
23d ago
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
PremiumCompany AnnouncementsBiohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
1M ago
Biohaven Expands At-The-Market Equity Offering Program
Premium
Company Announcements
Biohaven Expands At-The-Market Equity Offering Program
1M ago
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target
Premium
Ratings
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100